{"keywords": [{"value": "Drugs (Pharmaceuticals)", "rank": "1", "is_major": "Y", "name": "subject"}, {"value": "Lung Cancer", "rank": "2", "is_major": "Y", "name": "subject"}, {"value": "Merck & Company Inc", "rank": "3", "is_major": "Y", "name": "organizations"}, {"value": "Food and Drug Administration", "rank": "4", "is_major": "Y", "name": "organizations"}], "headline": {"print_headline": "U.S. Expands Approval of Merck Lung Cancer Drug ", "content_kicker": "Business Briefing", "main": "U.S. Expands Approval of Merck Lung Cancer Drug "}, "byline": {"contributor": "", "organization": "THE ASSOCIATED PRESS", "original": "By THE ASSOCIATED PRESS", "person": []}, "web_url": "http://www.nytimes.com/2015/10/03/business/us-expands-approval-of-merck-lung-cancer-drug.html", "source": "The New York Times", "subsection_name": null, "slideshow_credits": null, "type_of_material": "Brief", "_id": "560f084d38f0d83e166eaa82", "multimedia": [], "pub_date": "2015-10-03T00:00:00Z", "print_page": "2", "section_name": "Business Day", "word_count": "130", "blog": [], "news_desk": "Business", "snippet": "Federal health officials on Friday expanded approval of an innovative Merck drug to treat patients with an advanced form of the most common lung cancer.", "document_type": "article", "abstract": "Food and Drug Administration expands approval of Merck drug Keytruda for patients with advanced form of common lung cancer.", "lead_paragraph": "Federal health officials on Friday expanded approval of an innovative Merck drug to treat patients with an advanced form of the most common lung cancer."}